参考文献/References:
[1]Ping Z , Wen Z , Jinhua L , et al. Research on central sensitization of endometriosisassociated pain: a systematic review of the literature [J]. Journal of Pain Research, 2019, 12:14471456.
[2]Se M, Ks L, Cy S, et al. The biochemical basis of microRNA targeting efficacy [J]. Science (New York, N.Y.),2019,366:6472.
[3]Thomas, Treiber, Nora,et al. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways [J]. Nature reviews. Molecular cell biology,2019,20(1):520.
[4]Lfr G, Ij M. Regulation of microRNA function in animals [J]. Nature Reviews. Molecular Cell Biology,2019,20(1):2137.
[5]Y W, S G, X L, et al. Prognostic cancer gene signatures share common regulatory motifs [J]. Scientific Reports,2017,7(1):4750.
[6]R R, Fj S. MicroRNA therapeutics:towards a new era for the management of cancer and other diseases [J]. Nature Reviews. Drug Discovery,2017,16(3):203222.
[7]Bj R,Fj S,M B,et al.The 21nucleotide let7 RNA regulates developmental timing in Gaenorhabditis elegans [J].Nature,2000,403(6772):901906.
[8]Gilles M, Slack F J. Let7 microRNA as a potential therapeutic target with implications for immunotherapy [J]. Expert Opinion on Therapeutic Targets,2018,22(11):929939.
[9]Cy C, Ok C, Lw L, et al. MicroRNA let7TGFBR3 signalling regulates cardiomyocyte apoptosis after infarction [J]. EBioMedicine,2019,46:236247.
[10]S K, K W, R G, et al. Insilico investigations of selective miRNAgene targets and their validation studies in obstructive sleep apnea (OSA) patient cohorts [J]. Computational Biology and Chemistry,2020,87:107264.
[11]de Almeida BC, Lg D A, M U, et al. Let7 miRNA's expression profile and its potential prognostic role in uterine leiomyosarcoma [J]. Cells,2019,8(11):1452.
[12]D Y, X L, G H, et al. The let7 family of microRNAs suppresses immune evasion in head and neck squamous cell carcinoma by promoting PDL1 degradation [J]. Cell Communication and Signaling:CCS,2019,17(1):173.
[13]E P,R S,K K,et al.Analysis of let7 family miRNA in plasma as potential predictive biomarkers of diagnosis for papillary thyroid cancer [J].Diagnostics (Basel,Switzerland),2020,10(3):130.
[14]Ns B, A G, N T, et al. Evaluating prognostic utility of preoperative neutrophil to lymphocyte ratio and hsalet7g/c upregulation in patients with urinary bladder cancer [J]. Cancer Biomarkers:Section A of Disease Markers,2020,27(1):6373.
[15]Johnson S M, Grosshans H, Shingara J, et al. RAS is regulated by the let7 MicroRNA family [J]. Cell,2005,120(5):635647.
[16]Kumar M S, Erkeland S J, Pester R E, et al. Suppression of nonsmall cell lung tumor development by the let7 microRNA Family[J]. Proceedings of the National Academy of Sciences of the United States of America,2008,105(10):39033908.
[17]Trang P, Wiggins J F, Daige C L, et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice[J]. Molecular Therapy,2011,19(6):11161122.
[18]Yang X, Cai H, Liang Y, et al. Inhibition of cMyc by let7b mimic reverses mutidrug resistance in gastric cancer cells[J]. Oncology Reports,2015,33(4):17231730.
[19]H W, Y R, C Q, et al. Overexpression of CDX2 alleviates breast cancer by upregulating microRNA let7b and inhibiting COL11A1 expression [J]. Cancer Cell International,2020,20:13.
[20]Mm Q, X C, Hb H, et al. Let7i inhibits proliferation and migration of bladder cancer cells by targeting HMGA1 [J]. BMC urology,2019,19(1):53.
[21]Cho S, Mutlu L, Grechukhina O, et al. Circulating microRNAs as potential biomarkers for endometriosis[J]. Fertility and Sterility,2015,103(5):12521260.
[22]Seifer B J, Su D, Taylor H S. Circulating miRNAs in murine experimental endometriosis [J]. Reproductive Sciences,2017,24(3):376381.
[23]Xu X, Sun M, Ye J, et al. The effect of aromatase on the reproductive function of obese males [J]. Hormone and Metabolic research=Hormon und Stoffwechselforschung=Hormones et Metabolisme,2017,49(8):572.
[24]Cho S, Mutlu L, Zhou Y, et al. Aromatase inhibitor regulates let7 expression and let7finduced cell migration in endometrial cells from women with endometriosis[J]. Fertility and Sterility,2016,106(3):673680.
[25]Zhang P, Tillmans L S, Thibodeau S N, et al. Singlenucleotide polymorphisms sequencing identifies candidate functional variants at prostate cancer risk loci [J]. Genes,2019,10(7):547.
[26]Grechukhina O, Petracco R, Popkhadze S, et al. A polymorphism in a let7 microRNA binding site of KRAS in women with endometriosis [J]. EMBO Molecular Medicine,2012,4(3):206217.
[27]Liu Y, Hu J, Shen W, et al. Peritoneal fluid of patients with endometriosis promotes proliferation of endometrial stromal cells and induces COX2 expression [J]. Fertility and Sterility,2011,95(5):18361838.
[28]Santanam N, Kavtaradze N, Murphy A, et al. Antioxidant supplementation reduces endometriosisrelated pelvic pain in humans [J]. Translational Research,2013,161(3):189195.
[29]Qin B, Xiao B, Liang D, et al. MicroRNA let7c inhibits Bclxl expression and regulates oxLDLinduced endothelial apoptosis[J]. BMB Reports,2012,45(8):464469.
[30]Wright K R, Mitchell B, Santanam N. Redox regulation of microRNAs in endometriosisassociated pain[J]. Redox Biology,2017,12:956966.
[31]Wang T, Wang G, Hao D, et al. Aberrant regulation of the LIN28A/LIN28B and let7 loop in human malignant tumors and its effects on the hallmarks of cancer [J]. Molecular Cancer,2015,14(1):125.
[32]Bulun S E, Yang S, Fang Z, et al. Estrogen production and metabolism in endometriosis [J]. Annals of the New York Academy of Sciences,2002,955(1):7585.
[33]Shibahara Y, Miki Y, Onodera Y, et al. Aromatase inhibitor treatment of breast cancer cells increases the expression of let7f, a microRNA targeting CYP19A1[J]. The Journal of Pathology,2012,227(3):357366.
[34]Sahin C, Mamillapalli R, Yi K W, et al. microRNA Let7b: A novel treatment for endometriosis [J]. Journal of Cellular and Molecular Medicine,2018,22(11):53465353.
相似文献/References:
[1]苏慧明,徐燕,李晶,等.E-钙粘附素在子宫内膜异位症盆腔腹膜病灶的表达[J].中国计划生育和妇产科,2010,(01):0.
SU Hui-ming,XU Yan,LI Jing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(9):0.
[2]李桂兰.青春期子宫内膜异位症的诊治进展[J].中国计划生育和妇产科,2010,(03):0.
[3]韦晓娜,覃红萍.孕三烯酮配伍小剂量米非司酮治疗子宫内膜异位症64例效果观察[J].中国计划生育和妇产科,2010,(04):0.
[4]李成龙,冷金花.子宫内膜异位症与雌、孕激素受体关系的研究进展[J].中国计划生育和妇产科,2010,(04):0.
[5]关铮.深部浸润型子宫内膜异位症相关问题探讨[J].中国计划生育和妇产科,2011,(04):0.
[6]张瑞霞,刘增娟,谢伟,等.腹腔镜诊断盆腔子宫内膜异位症及对不孕症患者的疗效观察[J].中国计划生育和妇产科,2012,(02):0.
ZHANG Rui-xia,LIU Zeng-juan,XIE Wei,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(9):0.
[7]梁寿珺,范余娟,黄尹,等.血管内皮生长因子+936TC基因多态性同子宫内膜异位症遗传易感性的Meta分析[J].中国计划生育和妇产科,2012,(04):0.
LIANG Shou-jun,FAN Yu-juan*,HUANG Yin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(9):0.
[8]范俊,栾少红,李晓林,等.口服避孕药在子宫内膜异位症治疗中的作用[J].中国计划生育和妇产科,2013,(02):0.
FAN Jun,LUAN Shao-hong,LI Xiao-lin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(9):0.
[9]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[10]李素红,冯春蝶,付秀虹,等.Treg细胞及Foxp3在子宫内膜异位症患者的表达及临床意义[J].中国计划生育和妇产科,2014,(04):0.
LI Su-hong,FENG Chun-die,FU Xiu-hong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(9):0.